P2Y12


Also found in: Wikipedia.

P2RY12

A gene on chromosome 3q24-q25 that encodes a G protein-coupled receptor for various drugs as well adenosine and uridine nucleotides.

P2Y12

The adenosine diphosphate receptor on platelets. It is the target for drugs such as clopidogrel, prasugrel, or ticagrelor, which are used to inhibit platelet aggregation.
Mentioned in ?
References in periodicals archive ?
The potential adequacy of DAPT alone was also shown in a small study that showed no advantage to a triple therapy (TT) regimen involving aspirin, a P2Y12 inhibitor, and warfarin when compared with DAPT with aspirin and a P2Y12 inhibitor in preventing LVT and systemic embolism (13).
Clopidogrel is a prodrug for an active metabolite that blocks the platelet P2Y12 receptor.
Matthew Price: I use the VerifyNow P2Y12 test to assess platelet function, usually in patients who have presented with acute coronary syndrome and have been treated with clopidogrel before cardiac catheterization.
Researchers assessed platelet reactivity with the VerifyNow Aspirin, P2Y12, and IIb/IIIa tests.
ADP] The contribution of P2Y12 pathway to clot formation [MA.
In these instruments, ADP is contained in the reagents in order to initiate activity of the platelet P2Y12 receptor.
Clopidogrel, a P2Y12 platelet inhibitor, is approved for the treatment of acute coronary syndrome and for patients who have had a recent MI, recent stroke, or established peripheral artery disease.
Detection of P2Y12-receptor Blockade (Clopidogrel) in Patients with Cardiovascular Disease by Accumetrics VerifyNow[R] P2Y12 and INNOVANCE[R] PFA P2Y*
Thienopyridines inhibit the adenosine 5'-diphosphate P2Y12 receptor on platelets.
platelet inhibition as measured using the VerifyNowA' P2Y12 Test with a 60 mg
Inspire has significant technical and scientific expertise in the therapy areas of ophthalmology and respiratory and is a leader in the field of P2 receptor technology with a current focus on P2Y2 and P2Y12 receptors that show therapeutic promise.
Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, P2Y12 inhibitors (e.